Cargando…
Combination therapy of a mouse sarcoma using razoxane and electron irradiation.
The combination of a single dose of razoxane (ICRF 159) with a single dose of electron radiation has been studied with the murine sarcoma S180. A drug dose of 30 mg/kg combined with radiation produced a greater tumour response than either agent alone, but it was not possible to establish whether the...
Autores principales: | Grimshaw, M. B., Davies, R. W., Hall, W. S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1981
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010644/ https://www.ncbi.nlm.nih.gov/pubmed/7259958 |
Ejemplares similares
-
Razoxane-induced polyploidy.
por: Taylor, I. W., et al.
Publicado: (1978) -
Reduction of daunomycin toxicity by razoxane.
por: Wang, G., et al.
Publicado: (1981) -
The mutagenic activity of razoxane (ICRF 159): an anticancer agent.
por: Albanese, R., et al.
Publicado: (1985) -
The Radiation Response of Sarcomas by Histologic Subtypes: A Review
With Special Emphasis Given to Results Achieved With Razoxane
por: Rhomberg, Walter
Publicado: (2006) -
Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
por: Newman, C. E., et al.
Publicado: (1985)